KSE100 34350.42  ▲ Increased By 231.03 (0.68%)
KSE30 15000.89  ▲ Increased By 85.48 (0.57%)
BR100 3516.22  ▲ Increased By 11.22 (0.32%)
BR30 18244.64  ▲ Increased By 13.27 (0.07%)

Business Recorder Logo

Jun 06, 2020 PRINT EDITION
Business

J&J says FTC probing efforts to protect arthritis drug Remicade

WASHINGTON: The Federal Trade Commission in June issued civil subpoenas to Johnson and Johnson as part of an investi

July 29, 2019

WASHINGTON: The Federal Trade Commission in June issued civil subpoenas to Johnson and Johnson as part of an investigation of whether contracting practices for its blockbuster rheumatoid arthritis drug, Remicade, violated antitrust laws, the company said in a regulatory filing on Monday.

Shares of the company were trading marginally down at $132.47, after having closed up 1.7% on Monday.

Copyright Reuters, 2019